| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 729198 | 85379 | ALZIL PLUS 5 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ALZIL PLUS 5 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 5 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85379/85379_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85379/85379_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | FERRER INTERNACIONAL S.A. | 2020-09-07 | 1 | 1 | 1 | 2020-09-08 | 2020-09-07 | 1 | 2023-08-14 | View Edit Delete | ||||||||||||
| 729216 | 85389 | BUCOSIL 5 MG/5 MG COMPRIMIDOS PARA CHUPAR SABOR NARANJA | BUCOSIL 5 MG/5 MG COMPRIMIDOS PARA CHUPAR SABOR NARANJA, 20 comprimidos | 5 mg/5 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85389/85389_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85389/85389_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1778 | MEDICAL S.A. | 2020-09-07 | 1 | 1 | 1 | 2020-09-08 | 2020-09-07 | 1 | 2022-07-20 | View Edit Delete | ||||||||||||
| 729191 | LT-1-98-3805-025 | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/LT-1-98-3805-025/LT-1-98-3805-025_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | DIFARMED S.L.U. | 2020-09-07 | 1 | 1 | 1 | 2020-09-08 | 2020-09-07 | 1 | 2020-12-06 | View Edit Delete | ||||||||||||
| 729193 | LT-1-98-3805-025IP | ZARATOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ZARATOR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33758 | DIFARMED S.L.U. | 2020-09-07 | 1 | 1 | 1 | 2020-09-08 | 2020-09-07 | 1 | 2020-12-06 | View Edit Delete | ||||||||||||
| 729204 | 85380 | ASPIFOX 10 MG/100 MG CAPSULAS DURAS | ASPIFOX 10 MG/100 MG CAPSULAS DURAS, 30 cápsulas | 10 mg/100 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85380/85380_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85380/85380_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2020-09-07 | 1 | 1 | 1 | 2020-09-08 | 2020-09-07 | 1 | 2023-02-13 | View Edit Delete | ||||||||||||
| 729205 | 85381 | ASPIFOX 20 MG/100 MG CAPSULAS DURAS | ASPIFOX 20 MG/100 MG CAPSULAS DURAS, 30 cápsulas | 20 mg/100 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85381/85381_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85381/85381_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2020-09-07 | 1 | 1 | 1 | 2020-09-08 | 2020-09-07 | 1 | 2023-02-13 | View Edit Delete | ||||||||||||
| 729206 | 85382 | ASPIFOX 5 MG/100 MG CAPSULAS DURAS | ASPIFOX 5 MG/100 MG CAPSULAS DURAS, 30 cápsulas | 5 mg/100 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85382/85382_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85382/85382_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2020-09-07 | 1 | 1 | 1 | 2020-09-08 | 2020-09-07 | 1 | 2023-02-13 | View Edit Delete | ||||||||||||
| 729201 | 67161 | OXIGENO MEDICINAL LIQUIDO NIPPON GASES 99,5% v/v, GAS CRIOGENICO MEDICINAL EN RECIPIENTE CRIOGENICO FIJO | OXIGENO MEDICINAL LIQUIDO NIPPON GASES 99,5% v/v, GAS CRIOGENICO MEDICINAL EN RECIPIENTE CRIOGENICO FIJO, 1 recipiente criogénico fijo de 13.600 l | 99,5% v/v | 94 | 13.600 | 25 | 1 recipiente criogénico fijo de 13.600 l | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67161/67161_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67161/67161_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 72974 | NIPPON GASES ESPANA SLU | 2005-11-04 | 1 | 1 | 1 | 2005-11-04 | 2020-09-03 | 0 | 2022-10-03 | View Edit Delete | ||||||||||||
| 729066 | 1120807007 | TRESIBA 100 UNIDADES/ML PENFILL SOLUCION INYECTABLE EN CARTUCHO | TRESIBA 100 UNIDADES/ML PENFILL SOLUCION INYECTABLE EN CARTUCHO, 5 cartuchos de 3 ml | 100 U/ml inyectable 3 ml | 12 | 5 | 57 | 5 cartuchos de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1120807007/1120807007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1120807007/1120807007_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1974 | NOVO NORDISK PHARMA S.A. | 2020-09-02 | 1 | 1 | 1 | 2020-09-03 | 2020-09-02 | 1 | 2022-12-27 | View Edit Delete | ||||||||||||
| 729114 | 1201460001 | ROZLYTREK 100 MG CAPSULAS DURAS | ROZLYTREK 100 MG CAPSULAS DURAS, 30 cápsulas | 100 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201460001/1201460001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201460001/1201460001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 2020-08-27 | 1 | 1 | 1 | 2020-08-28 | 2020-08-27 | 1 | 2023-11-13 | View Edit Delete | ||||||||||||
| 729115 | 1201460002 | ROZLYTREK 200 MG CAPSULAS DURAS | ROZLYTREK 200 MG CAPSULAS DURAS, 90 cápsulas | 200 mg | 6 | 90 | 43 | 90 cápsulas | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201460002/1201460002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201460002/1201460002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 2020-08-27 | 1 | 1 | 1 | 2020-08-28 | 2020-08-27 | 1 | 2023-11-13 | View Edit Delete | ||||||||||||
| 729173 | 71372 | CLOPIDOGREL SANDOZ 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CLOPIDOGREL SANDOZ 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG,84 comprimidos | 75 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71372/71372_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71372/71372_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2009-09-11 | 1 | 1 | 1 | 2009-09-11 | 2020-08-26 | 0 | 2021-02-09 | View Edit Delete | ||||||||||||
| 729116 | 1201455002 | PIQRAY 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | PIQRAY 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos | 150 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201455002/1201455002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201455002/1201455002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-08-25 | 1 | 1 | 1 | 2020-08-26 | 2020-08-25 | 1 | 2021-11-11 | View Edit Delete | ||||||||||||
| 729126 | 1201455005 | PIQRAY 50 MG y 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | PIQRAY 50 MG y 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos (28 x 50 mg + 28 x 200 mg) | 50 mg + 200 mg | 5 | 56 | 10 | 56 comprimidos (28 x 50 mg + 28 x 200 mg) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201455005/1201455005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201455005/1201455005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-08-25 | 1 | 1 | 1 | 2020-08-26 | 2020-08-25 | 1 | 2021-11-11 | View Edit Delete | ||||||||||||
| 729127 | 1201455008 | PIQRAY 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | PIQRAY 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 200 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201455008/1201455008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201455008/1201455008_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-08-25 | 1 | 1 | 1 | 2020-08-26 | 2020-08-25 | 1 | 2021-11-11 | View Edit Delete | ||||||||||||
| 729167 | 81297 | OMEPRAZOL ALTER 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL ALTER 20 MG CAPSULAS DURAS GASTRORRESISTENTES EFG, 56 cápsulas (PVC/PVDC/AL) | 20 mg | 5 | 56 | 43 | 56 cápsulas (PVC/PVDC/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81297/81297_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81297/81297_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2016-10-10 | 1 | 1 | 1 | 2016-10-11 | 2020-08-21 | 1 | 2020-11-30 | View Edit Delete | ||||||||||||
| 729125 | 85353 | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA TEVA 10 MG/320 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA TEVA 10 MG/320 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 320 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85353/85353_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85353/85353_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2020-08-19 | 1 | 1 | 1 | 2020-08-20 | 2020-08-19 | 0 | 2020-11-13 | View Edit Delete | ||||||||||||
| 728878 | 1201452001 | REBLOZYL 25 MG POLVO PARA SOLUCION INYECTABLE | REBLOZYL 25 MG POLVO PARA SOLUCION INYECTABLE, 1 vial | 25 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201452001/1201452001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201452001/1201452001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2020-08-18 | 1 | 1 | 1 | 2020-08-20 | 2020-08-18 | 1 | 2023-08-03 | View Edit Delete | ||||||||||||
| 728879 | 1201452002 | REBLOZYL 75 MG POLVO PARA SOLUCION INYECTABLE | REBLOZYL 75 MG POLVO PARA SOLUCION INYECTABLE, 1 vial | 75 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201452002/1201452002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201452002/1201452002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2020-08-18 | 1 | 1 | 1 | 2020-08-20 | 2020-08-18 | 1 | 2023-08-03 | View Edit Delete | ||||||||||||
| 728355 | 85023 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA VIATRIS 40 MG/5 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA VIATRIS 40 MG/5 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85023/85023_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85023/85023_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L.U. | 2020-08-12 | 1 | 1 | 1 | 2020-08-12 | 2020-08-12 | 1 | 2020-11-11 | View Edit Delete |
Page 241 of 1036, showing 20 records out of 20704 total, starting on record 4801, ending on 4820